妈咪爱品牌怎么样 申请店铺

我要投票 妈咪爱在益生菌行业中的票数:730 更新时间:2026-01-29
妈咪爱是哪个国家的品牌?「妈咪爱」是 北京韩美药品有限公司 旗下著名品牌。该品牌发源于韩国,由创始人林盛基在1996-03-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力妈咪爱品牌出海!将品牌入驻外推网,定制妈咪爱品牌推广信息,可以显著提高妈咪爱产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

妈咪爱怎么样

成立于1996年,益生菌十大品牌,韩国韩美集团和北京紫竹投资的大型现代化制药公司,涉及儿科/消化科/骨科/抗感染药等领域


北京韩美药品有限公司(以下简称北京韩美)成立于1996年3月,设立在环境优美的北京市顺义空港开发区,占地面积13600平米。

北京韩美除总部外,还设有研究中心、GMP工厂及遍布全国的销售团队,并于2008年成立了“业务中心”(Business center),集“研发、生产、销售”三位于一体。其中,GMP工厂严格按GMP标准精心设计建造,于2001年12月通过了国家药品监督局的GMP认证并正式投产使用,又于2015年底通过了新版GMP认证。研究中心面积有近4000平方米,包括生物实验室、化学合成实验室和药理毒理实验室,配备多种药物研究设备,与国外的研发中心、韩美药品总部、韩美精细化工厂及配方研发中心紧密合作,构成了全球研发网络。销售团队遍及国内各省、自治区、直辖市及数百个市、县。

公司产品业务涉及儿科产品、消化科产品、骨科产品、抗感染药等领域,98%的产品在国内成产,主要产品有妈咪爱、易坦静、美常安、利动、醋氯芬酸、锐迈等十几个品种。其中妈咪爱、易坦静已成为中国儿童基本常备药,深受广大医生和儿童家长的欢迎。


Founded in 1996, it is a large modern pharmaceutical company invested by Korean American group and Beijing Zizhu, a top ten probiotics brand. Beijing Korean American Pharmaceutical Co., Ltd. (hereinafter referred to as Beijing Korean American) involving paediatrics / gastroenterology / orthopedics / anti infectives and other fields was founded in March 1996, and it is located in Shunyi Airport Development Zone of Beijing with beautiful environment, covering an area of 13600 square meters. In addition to its headquarters, Beijing Hanmei also has a research center, GMP factory and sales team all over the country. In 2008, it established a "business center", which integrates "R & D, production and sales". Among them, the GMP factory was carefully designed and built in strict accordance with GMP standards. In December 2001, it passed the GMP certification of the State Drug Administration and was officially put into operation. At the end of 2015, it passed the new GMP certification. The research center covers an area of nearly 4000 square meters, including biological laboratory, chemical synthesis laboratory and pharmacology and toxicology laboratory, equipped with a variety of drug research equipment, and has formed a global R & D network in close cooperation with foreign R & D centers, Korean American drug headquarters, Korean American fine chemical plants and formula R & D centers. The sales team covers all provinces, autonomous regions, municipalities directly under the central government and hundreds of cities and counties in China. The company's product business involves pediatric products, digestive products, orthopedic products, anti infective drugs and other fields. 98% of the products are produced in China, and the main products include more than ten varieties such as Mami AI, Yitanjing, meichang'an, Lidong, aceclofenac, Ruimai, etc. Among them, mami AI and Yi Tanjing have become the basic medicines for children in China, which are welcomed by doctors and parents of children.

本文链接: https://brand.waitui.com/3b3677d18.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

苹果据悉今年9月只上iPhone18 Pro系列和首款阔折叠Fold

市场消息称,苹果iPhone 18预计明年Q1推出,9月只上iPhone18 Pro系列和首款阔折叠iPhone Fold,基本都是万元机档位。苹果今年秋季发布的所有新款iPhone都配备12GB内存,涵盖iPhone 18 Pro、iPhone 18 Pro Max以及iPhone Fold(折叠屏 iPhone),与 iPhone 17 Pro系列所采用的12GB内存保持一致。(财联社)

2小时前

美股大型科技股盘前多数上涨,英特尔涨超5%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,英特尔涨超5%,英伟达涨超2%,谷歌涨0.44%,亚马逊涨0.22%,微软涨0.31%,特斯拉涨0.19%,Meta跌0.28%,苹果跌0.19%。

2小时前

热门中概股美股盘前普涨,哔哩哔哩涨超4%

36氪获悉,热门中概股美股盘前普涨,截至发稿,哔哩哔哩涨超4%,蔚来、理想汽车涨超3%,阿里巴巴、网易、小鹏汽车涨超2%,百度涨超1%,拼多多涨0.61%,京东涨0.54%。

2小时前

星巴克:第一季度美国同店销售额增长4% 高于市场预期

星巴克第一季度美国同店销售额增长4%,预估为增长1.88%。星巴克预计全年同店销售至少增长3%,市场预估增长2.83%;预计全年调整后每股收益2.15美元至2.40美元。(财联社)

2小时前

*ST铖昌:预计2025年净利润9500万元-1.24亿元,公司股票存在可能被终止上市的风险

36氪获悉,*ST铖昌公告,*ST铖昌预计2025年归属于上市公司股东的净利润为9500万元–12400万元,上年同期为亏损3111.79万元,同比扭亏为盈。公司股票因2024年度经审计净利润为负值且扣除后营业收入低于3亿元,自2025年4月24日起被实施退市风险警示。若公司2025年度出现《深圳证券交易所股票上市规则》第9.3.12条规定的相关情形,公司股票将面临被终止上市的风险。公司已披露股票可能被终止上市的风险提示公告,并计划更换会计师事务所以推进2025年度审计工作。

2小时前

本页详细列出关于妈咪爱的品牌信息,含品牌所属公司介绍,妈咪爱所处行业的品牌地位及优势。
咨询